| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.19 | 0.2 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |